Predictors of Long-term Persistence on Statins in a Subsidized Clinical Population
Authors:
- Jacques LeLorierJLJacques LeLorier
- 1 November 2000
- journal article
- Published by Elsevier in Value in Health
- Vol. 3 (6) , 417-426
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Incontinence Drug Utilization Patterns in Québec, CanadaValue in Health, 1999
- Persistence of Use of Lipid-Lowering MedicationsJAMA, 1998
- Compliance with and efficacy of treatment with pravastatin and cholestyramine: a randomized study on lipid‐lowering in primary careJournal of Internal Medicine, 1998
- The Cost of Treating Dyslipidaemia Using National Cholesterol Education Program (NCEP) GuidelinesPharmacoEconomics, 1998
- Clinical positioning of HMG-CoA reductase inhibitors in lipid management protocols.PharmacoEconomics, 1998
- Apparent discontinuation rates in patients prescribed lipid‐lowering drugsMedical Journal of Australia, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- The use of prescription claims databases in pharmacoepidemiological research: The accuracy and comprehensiveness of the prescription claims database in QuébecJournal of Clinical Epidemiology, 1995
- Discontinuation of Antihyperlipidemic Drugs — Do Rates Reported in Clinical Trials Reflect Rates in Primary Care Settings?New England Journal of Medicine, 1995
- A chronic disease score from automated pharmacy dataJournal of Clinical Epidemiology, 1992